Department of Medicine
Caner Saygin is a physician-scientist whose translational research laboratory is focused on understanding leukemia biology and genetics, as well as developing novel therapies for these diseases. He studies the mechanisms by which leukemias arise from precursor conditions such as clonal hematopoiesis, working with primary cells from patient samples and modeling these entities in his laboratory. He was involved in preclinical development of several experimental therapeutics for treatment of acute leukemias. Saygin is focused on the development and conduct of novel therapeutic trials for these diseases, both at the institutional and national level.
His work has been published in Cell Stem Cell, Journal of Experimental Medicine, Leukemia, Clinical Cancer Research, and Blood Advances. He is a recipient of the Leukemia & Lymphoma Society (LLS) Career Development award, the LLS Academic Clinical Trials award, the American Society of Hematology Research Training Award for Fellows, the American Society of Clinical Oncology Young Investigator Award, the Cancer Research Foundation Young Investigator Award, and the Prevent Cancer Foundation Fellowship.
Saygin received an MD from Istanbul University, followed by a postdoctoral fellowship at the Cleveland Clinic Lerner Research Institute, an internal medicine residency at The Ohio State University, and hematology-oncology subspecialty training at the University of Chicago.